GLP-1 Medications and Shoulder Surgery

GLP-1 medications such as semaglutide and tirzepatide are increasingly common for weight loss and diabetes management.

Unlike many experimental peptides, GLP-1 medications have approved medical uses and may be highly relevant to surgical preparation, metabolic health, and recovery.

Why GLP-1 medications matter before surgery

Obesity, diabetes, insulin resistance, inflammation, and poor metabolic health can affect surgical risk and recovery.

Improving metabolic health before shoulder surgery may help with:

• Blood sugar control
• Weight reduction
• Anesthesia risk reduction
• Inflammation burden
• Mobility and rehabilitation tolerance
• Overall surgical readiness

Important risks and considerations

GLP-1 medications can also create challenges around surgery.

• Nausea or reduced appetite
• Inadequate protein intake
• Lean muscle loss during rapid weight loss
• Dehydration
• Delayed gastric emptying
• Anesthesia-related fasting considerations

Patients taking these medications should make sure their surgical and anesthesia teams know well before surgery.

Shoulder surgery recovery and muscle preservation

Weight loss can be beneficial, but rapid weight loss without adequate protein and resistance training may reduce lean muscle mass.

This matters because shoulder recovery depends on:

• Deltoid strength
• Rotator cuff function
• Scapular control
• General conditioning
• Ability to participate in rehabilitation

Patients using GLP-1 medications should prioritize protein, hydration, strength maintenance, and medical supervision.

What this means for shoulder patients

GLP-1 medications may be helpful for selected patients preparing for shoulder surgery, especially when obesity, diabetes, or metabolic health are concerns.

The goal is not simply weight loss. The goal is surgical readiness: better metabolic health, adequate nutrition, preserved muscle, and safer recovery.